Custom Peptide Synthesis Company Custom Antibody Synthesis
  Home |  About BSI My BiosynthesisServices New ProductsDistributors | SpecialsGizmo |  Tech LoungeTestimonials Forum |  Contact Us Login
     
     
Special voucher reward with new publication... 
Bio-Synthesis has teamed up with BioConference Live for a revolutionary event. 
Bio-Synthesis, Inc. Launches Peptide Library Generation Tools Software 
All Highlights   All Events
  Enter Keyword  
   
 
 
     
   
   
   
 
View Our Blog
   
 
     
 
Find Us On
 
   
   
Ribosomal RNA Analysis Custom RNA Synthesis DNA RNA Standard DNA vs. RNA Chimera Custom RNA Synthesis
 
Custom LNA Synthesis Nucleic Acid Synthesis LNA Oligos LNA Chimeras
 
Custom LNA (Lock Nucleic Acid Synthesis), Locked Nucleic Acid (LNA) was first described by Wengel and co-workers in 1998 as a novel class of conformationally restricted oligonucleotide analogues. LNA is a bicyclic nucleic acid where a ribonucleoside is linked between the 2'-oxygen and the 4'-carbon atoms via a methylene unit.

Oligonucleotides containing LNA exhibit unprecedented thermal stability towards complementary DNA and RNA2, which allows excellent mismatch discrimination. In fact, the high binding affinity of LNA oligos is recommended for use in any hybridization assay that requires high specificity and/or reproducibility such as
Dual labeled probes
In situ hybridization probe
SNP genotyping
DNA MicroArray expression analysis
Allele Specific PNA
mRNA sample preparation
Molecular Beacons and PCR primers
As a result of these significant characteristics, the use of LNA-modified oligos in antisense drug development is now coming under investigation4 and, recently, the therapeutic potential of LNA has been reviewed.5
BSI offers LNA synthesis with great flexibility. For more information on custom LNA synthesis, call 800-227-0627 or write to us at biosyn@biosyn.com

 

LNA Synthesis LNA Modification

Dual Labeled Probes

LNA Conjugations LNA Chimeras
 
Deprotected, desalted and ready to use
Multi-scale capacities
Purification by PAGE or RP-HPLC upon request
QC analysis by MALDI-TOF Mass spectrometry, HPLC, PAGE analysis
Fast delivery with high throughput capacity
   
References:
(1a) A.A. Koshkin, S.K. Singh, P. Nielsen, V.K. Rajwanshi, R. Kumar, M. Meldgaard, C.E. Olsen, and J. Wengel, Tetrahedron,1998, 54, 3607-3630.
(1b) S.K. Singh, P. Nielsen, A.A. Koshkin, and J. Wengel, Chem. Comm., 1998, (4), 455-456.
(2) L. Kværnø and J. Wengel, Chem. Comm., 1999, (7), 657-658.
(3) P. Mouritzen, A.T. Nielsen, H.M. Pfundheller, Y. Choleva, L. Kongsbak, and S. Møller, Expert Review of Molecular Diagnostics, 2003, 3(1), 27-38.
(4a) J. Kurreck, E. Wyszko, C. Gillen, and V.A. Erdmann, Nucleic Acids Res., 2002, 30, 1911-1918.
(4b)H. Ørum and J. Wengel, Curr. Opinion in Mol. Therap., 2001, 3, 239-243.
(5a) M. Petersen and J. Wengel, Trends in Biotechnology, 2003, 21(2), 74-81.
(5b) D.A. Braasch, D.R. Corey, Biochemistry, 2002, 41, 4503-4510.
     

The most trusted name in Quality Custom Synthesis.